Spironolactone Tablet
Product Images NDC 67296-2319

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 67296-2319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig (Spironolactone Fig1)

A Kaplan-Meier survival probability curve comparing Spironolactone (n=822) and placebo (n=841) over a 48-month period. The vertical axis represents probability, and the horizontal axis shows time in months. The graph includes a log-rank p-value of less than 0.001, indicating statistical significance.*

FDA Label Image

Fig (Spironolactone Fig2)

A forest plot chart showing hazard ratios (HR) and 95% confidence intervals for various subgroups related to a medical study. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, use of digoxin, ACE inhibitors, and beta blockers. The x-axis ranges from 0.2 to 1.4 with labels indicating 'Spironolactone better' on the left and 'Placebo better' on the right.*

FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))

Label for Spironolactone Tablets USP 25 mg, 100 tablets per container. The label shows the NDC 72603-134-01 and indicates prescription use only (Rx only). Manufactured by Aurobindo Pharma Limited and distributed by Northstar Rx LLC. Storage instructions specify 20° to 25°C and protection from light.*

FDA Label Image

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))

Label for Spironolactone Tablets USP 50 mg by NorthStar, containing 100 tablets. The label includes storage instructions, dosage references, and manufacturing details for Northstar Rx LLC and Aurobindo Pharma Limited. The label also features a barcode and an issuance date of 03/2023.*

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Tablets Bottle))

Label for Spironolactone Tablets, USP 100 mg in a bottle of 100 tablets, manufactured by Aurobindo Pharma Limited for Northstar Rx LLC. The label displays storage instructions at 20° to 25°C and notes protection from light. It includes NDC 72603-136-01 and batch/packaging information with a barcode on the right.*

FDA Label Image

Str (Spironolactone Str1)

Chemical structure of spironolactone, showing the molecular arrangement of atoms and bonds typical for this active ingredient in tablet form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.